Gomollón F - Search Results

1

Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA.

Gargallo-Puyuelo CJ, Ricart E, Iglesias E, de Francisco R, Gisbert JP, Taxonera C, Mañosa M, Aguas Peris M, Navarrete-Muñoz EM, Sanahuja A, Guardiola J, Mesonero F, Rivero Tirado M, Barrio J, Vera Mendoza I, de Castro Parga L, García-Planella E, Calvet X, Martín Arranz MD, García S, Sicilia B, Carpio D, Domenech E, Gomollón F; ENEIDA registry of GETECCU. Gargallo-Puyuelo CJ, et al. Among authors: gomollon f. Clin Gastroenterol Hepatol. 2024 Nov;22(11):2280-2290. doi: 10.1016/j.cgh.2024.05.013. Epub 2024 May 22. Clin Gastroenterol Hepatol. 2024. PMID: 38782172

2

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Gisbert JP, Gomollón F, Maté J, Pajares JM. Gisbert JP, et al. Among authors: gomollon f. Dig Dis Sci. 2002 Mar;47(3):471-88. doi: 10.1023/a:1017987229718. Dig Dis Sci. 2002. PMID: 11911332 No abstract available.

3

[Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].

Gisbert JP, Gomollón F, Cara C, Luna M, González-Lama Y, Pajares JM, Maté J, Guijarro LG. Gisbert JP, et al. Among authors: gomollon f. Med Clin (Barc). 2005 Sep 10;125(8):281-5. doi: 10.1157/13078420. Med Clin (Barc). 2005. PMID: 16159550 Spanish.

4

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

Gisbert JP, Calvet X, Gomollón F, Monés J; Grupo Conferencia Española de Consenso sobre Helicobacter pylori. Gisbert JP, et al. Among authors: gomollon f. Med Clin (Barc). 2005 Sep 10;125(8):301-16. doi: 10.1157/13078424. Med Clin (Barc). 2005. PMID: 16159556 Review. Spanish. No abstract available.

5

What is potent acid inhibition, and how can it be achieved?

Calvet X, Gomollón F. Calvet X, et al. Among authors: gomollon f. Drugs. 2005;65 Suppl 1:13-23. doi: 10.2165/00003495-200565001-00004. Drugs. 2005. PMID: 16335854 Review.

6

Optimising acid inhibition treatment.

Gomollón F, Calvet X. Gomollón F, et al. Drugs. 2005;65 Suppl 1:25-33. doi: 10.2165/00003495-200565001-00005. Drugs. 2005. PMID: 16335855 Review.

7

[Common errors in the management of the seriously ill patient with inflammatory bowel disease].

Gisbert JP, Gomollón F. Gisbert JP, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2007 May;30(5):294-314. doi: 10.1157/13101982. Gastroenterol Hepatol. 2007. PMID: 17493441 Review. Spanish. No abstract available.

8

[Common errors in the management of outpatients with inflammatory bowel disease].

Gisbert JP, Gomollón F. Gisbert JP, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2007 Oct;30(8):469-86. doi: 10.1157/13110491. Gastroenterol Hepatol. 2007. PMID: 17949615 Review. Spanish. No abstract available.

9

Crohn's disease: a review of current treatment with a focus on biologics.

Panés J, Gomollón F, Taxonera C, Hinojosa J, Clofent J, Nos P. Panés J, et al. Among authors: gomollon f. Drugs. 2007;67(17):2511-37. doi: 10.2165/00003495-200767170-00005. Drugs. 2007. PMID: 18034589 Review.

10

Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.

Gisbert JP, Gomollón F. Gisbert JP, et al. Among authors: gomollon f. Am J Gastroenterol. 2008 May;103(5):1299-307. doi: 10.1111/j.1572-0241.2008.01846.x. Am J Gastroenterol. 2008. PMID: 18477354 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters